Paper Publications
-
[1] Li, Yunhai. Predicting Drug-Target Affinity Using Protein Pocket and Graph Convolution Network. 20th International Symposium on Bioinformatics Research and Applications, ISBRA 2024, 14954 LNBI, 1-12, 2024.
-
[2] Yu, Jiating. Reverse network diffusion to remove indirect noise for better inference of gene regulatory networks. Bioinformatics, 40, 2024.
-
[3] 吴秋琴. Identification of DNA motif pairs on paired sequences based on composite heterogeneous graph. Frontiers in Genetics, 15, 2024.
-
[4] Jiating Yu. Incorporating network diffusion and peak location information for better single-cell ATAC-seq data analysis. Briefings in Bioinformatics, 25, 2024.
-
[5] Yang, Jiaxin. Multi-objective Optimization-Based Approach for Detection of Breast Cancer Biomarkers. 19th International Conference on Intelligent Computing, ICIC 2023, 14088 LNCS, 716-726, 2023.
-
[6] Sun, Chenxi. Detecting Autism Spectrum Disorder from Functional Magnetic Resonance Imaging Data with an Ensemble Machine Learning Method. 5th International Conference on Intelligent Medicine and Image Processing, IMIP 2023, 13-20, 2023.
-
[7] Zhang, Chunxiao. MOFNet: A Deep Learning Framework of Integrating Multi-omics Data for Breast Cancer Diagnosis. 19th International Conference on Intelligent Computing, ICIC 2023, 14088 LNCS, 727-738, 2023.
-
[8] . CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphoma. Mol Cancer, 22, 2023.
-
[9] Yu, Jiating. Network Refinement: Denoising complex networks for better community detection. PHYSICA A, 617, 2023.
-
[10] Wang, Chuanyuan. ActivePPI: quantifying protein-protein interaction network activity with Markov random fields. Bioinformatics (Oxford, England), 39, 2023.
-
[11] Identifying phenotype-associated subpopulations by integrating bulk and single-cell sequencing data. Nature Biotechnology, 2021.
-
[12] Postpartum breast cancer has a distinct molecular profile that predicts poor outcomes. Nature Communications, 2021.
-
[13] BET bromodomain inhibition blocks an AR-Repressed, E2F1-Activated treatment-emergent neuroendocrine prostate cancer lineage plasticity program. Clinical Cancer Research, 2021.
-
[14] Discovering cooperative biomarkers for heterogeneous complex disease diagnoses. Briefings in Bioinformatics, 2019.
